Stocks that hit the daily limit up or down in the morning session.
■ Stocks with daily price increase limit <269A> Sapeet <3779> Jay Escom Holdings <6391> Kachi Tech <7901> Matsumoto■ Stocks with daily price decrease limit <4664> RSC <6961> Emplus※ Includes temporarily suspended trading limits (indicative values).
List of conversion stocks (Part 3) [List of parabolic signal conversion stocks]
○ List of buy conversion stocks Market Code Stock name Closing price SAR TSE main board <7130> Yamae Group HD 1969 1808 <7239> Tachies 1774 1726 <7246> Press Works 5545 3939 <7272> Yamaha 1354 1281 <7280> Mitsuba 8838 837 <7388> FP Partner 2955 2608 <7419> Nojima 2150 1953 <7447> Nagailebe 229
Stocks with attractive characteristics seen from volume changes, such as GameWith, etc.
Stock closing prices volume comparison * <2721> JHD 178,271,397,100 * <4308> J Stream 36,629,970,400 * <6552> GameWith 24,550,692,050 * <8166> Takakyu 13,342,800,800 * <4777> Gala 24,850,372,400 * <7919> Nozaki printing 1,526,202,400 * <9307> Sugimura Warehouse 6,184,272,800 * <5820> Mitsuboshi 9,427,449,900 * <1964> Chugairo 29
Denso, etc., announced a share buyback on October 31st.
The following are the stocks that announced the establishment of a share buyback framework on October 31st (Thu) <8141> Shinko Shoji 3.77 million shares (9.9%) 3.1 billion 92.04 million yen 2600 yen (24/11/1-25/1/31) <6902> Denso 0.2 billion 80 million shares (9.6%) 450 billion yen (24/11/1-25/10/27) <9104> Mitsui O.S.K. Lines 30 million shares (8.3%) 100 billion yen (24/11/1-25/10/31) <7741> HOYA 3 million shares
Asahi Kasei, TDK, Mitsui Chemicals, kddi corporation (1st day)
※Please note that the above calendar is subject to change depending on the company's circumstances.---------------------------------------November 1st (Friday)<2229>Calbee <2282>Nippon Ham<2296>Itoham Yonekyu Holdings <2349>NIID <2440>Gurunavi <2480>Sysmex<2551>MarsaInc <2730>Edion<27
Canon Inc-spons adr, 3Q operating profit increased by 14.4% to 296.6 billion yen.
Canon Inc-Spons ADR <7751> announced its third quarter financial results for the fiscal year ending December 2024, with revenue increasing by 7.3% year-on-year to 3 trillion 236.1 billion 11 million yen, operating profit increasing by 14.4% to 296.6 billion 38 million yen. The gross profit margin increased by 0.8 points from the same period last year to 47.8%, due to cost reductions and favorable product mix, with gross profit also increasing by 7.1% year-on-year to 516.4 billion yen. [Positive evaluation] Takeda Pharmaceuticals Mid-Term <4502> | <7735> S